Cassie Jung sold $311K of Aquestive Therapeutics (AQST)

Executed Sep 4 2025, disclosed Sep 8 2025, 4 days later.

Value, as filed

$311K

62,180 sh × $5.00

Executed

Sep 4 2025

the trade date, as filed

Disclosed

Sep 8 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CJ Cassie Jung Chief Operating Officer profile →

Cassie Jung (Chief Operating Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Aquestive Therapeutics, Inc. (AQST). The largest single filing was $474K of AQST (67,575 sh × $7.01, as filed), executed Oct 15 2025.

The name

AQST Aquestive Therapeutics, Inc. AQST · Healthcare · 14 filings in 24 months ticker →

Healthcare · Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Cassie Jung in AQST

AQSTSALE Aquestive Therapeutics, Inc. $191K
45,791 sh × $4.17
Exec Mar 10
Filed Mar 11 · 5:30 PM ET AQSTSALE Aquestive Therapeutics, Inc. $474K
67,575 sh × $7.01
Exec Oct 15 2025
Filed Oct 17 2025 · 5:30 PM ET